Section 2500-C. Special programs with respect to diethylstilbestrol

1. For
  the  purpose  of  identifying  persons  who  have  been  exposed  to the
  potential hazards and afflictions of  diethylstilbestrol,  and  for  the
  purpose  of  educating the public concerning the symptoms and prevention
  of associated malignancies, the commissioner  shall  establish,  promote
  and  maintain  a public information campaign on diethylstilbestrol. Such
  campaign shall be conducted throughout the state and shall  include  but
  not  be  limited  to a concerted effort at reaching those persons or the
  offspring of persons who have  been  exposed  to  diethylstilbestrol  in
  order  to  encourage  them  to  seek  medical care for the prevention or
  treatment of any malignant condition.
    2. (a) The commissioner shall designate and enter into contracts  with
  providers  of  health  care  for  the  purpose  of establishing regional
  screening  programs   for   diethylstilbestrol   exposed   persons.   In
  determining  the provider with which to contract, the commissioner shall
  consider such provider's compliance with state  and  federally  mandated
  standards,  the location in relation to the geographical distribution of
  persons exposed to diethylstilbestrol, and the capacity of such provider
  to properly screen for breast cancer, vaginal cancer,  cervical  cancer,
  vaginal  adenosis,  testicular  cancer  and  any  other  malignancy  and
  abnormal conditions resulting from DES exposure.
    (b) Each contract for a regional screening program shall be upon  such
  terms  and conditions as the commissioner determines, provided, however,
  that expenses incurred shall be reimbursed by the state  after  applying
  against  the  total cost of screening and diagnosis the amounts received
  from third party payers and less any fee charged each  person  receiving
  such services where the commissioner shall determine a sliding fee scale
  based on ability to pay.
    3.  Each  provider  of  health  care  that  enters  into a contract as
  provided for in  this  section  shall  conduct  a  training  program  in
  conjunction  with the department for purposes of instructing physicians,
  physician assistants and nurses within  the  respective  health  systems
  agency   in  the  detection,  diagnosis,  treatment  and  prevention  of
  diethylstilbestrol exposed persons.
    4. The bureau of cancer control within  the  health  department  shall
  establish  and  maintain a registry of women who took diethylstilbestrol
  during   pregnancy   and   their   offspring   who   were   exposed   to
  diethylstilbestrol  prenatally  for  the  purpose  of follow-up care and
  treatment of  long  term  problems  associated  with  diethylstilbestrol
  exposure. Enrollment in the registry shall be upon a voluntary basis.
    5. The commissioner may request and shall receive from any department,
  division,  board,  bureau,  commission  or agency of the state or of any
  political subdivision thereof such assistance and data  as  will  enable
  him  to  properly  carry out his activities hereunder and effectuate the
  purposes herein set forth.   The commissioner may also  enter  into  any
  contract  for  services  as  he deems necessary with a private agency or
  concern upon said terms and conditions as he deems appropriate.
    6. The department shall make an annual report to  the  legislature  of
  its  findings  and  recommendations concerning the effectiveness, impact
  and benefits derived from the special programs as provided for  in  this
  section.  Such  report  shall be delivered on or before the first day of
  February and shall contain evaluations of such special programs, and any
  legislation deemed necessary and proper.
    7. Special programs as provided for in this section shall be conducted
  within the appropriation made therefor.